Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized phase III trial.
Saved in:
| Title: | Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized phase III trial. |
|---|---|
| Authors: | Correale P; Radiotherapy Unit §Medical Oncology Unit, Department of Oncology, Microbiology Section ∥Department of Biotechnology ¶Rheumatology Unit, Department of Medicine #Pharmacy Unit, Siena University Hospital 'Santa Maria alle Scotte', Istituto Toscano Tumory, Siena †Medical Oncology Unit ‡Department of Legal, Historical, Economic and Social Sciences-DSGSES, Magna Graecia University of Catanzaro ††Translational Medical Oncology Unit, 'Magna Graecia' University and 'Tommaso Campanella' Cancer Center, Campus 'Salvatore Venuta,' Catanzaro **Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples ‡‡Chemotherapy Unit, Department of Oncology, Florence University School of Medicine, Florence §§Medical Oncology Unit, Department of Oncology, Cagliari University School of Medicine, Cagliari ∥∥Medical Oncology Unit, Centro Oncologico Romagnolo, Forlì, Italy., Botta C, Rotundo MS, Guglielmo A, Conca R, Licchetta A, Pastina P, Bestoso E, Ciliberto D, Cusi MG, Fioravanti A, Guidelli GM, Bianco MT, Misso G, Martino E, Caraglia M, Tassone P, Mini E, Mantovani G, Ridolfi R, Pirtoli L, Tagliaferri P |
| Source: | Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2014 Jan; Vol. 37 (1), pp. 26-35. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1537-4513 |
|---|---|
| DOI: | 10.1097/CJI.0000000000000004 |
